Trial Outcomes & Findings for Multi-catheter High Dose Rate (HDR) Breast Brachytherapy (NCT NCT00214149)
NCT ID: NCT00214149
Last Updated: 2018-11-05
Results Overview
TERMINATED
PHASE2
127 participants
5 years
2018-11-05
Participant Flow
Participant milestones
| Measure |
Breast Brachytherapy to 34 Gy
breast brachytherapy to a dose of 34 Gy
brachytherapy: breast brachytherapy to 34 Gy
|
|---|---|
|
Overall Study
STARTED
|
127
|
|
Overall Study
COMPLETED
|
0
|
|
Overall Study
NOT COMPLETED
|
127
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Multi-catheter High Dose Rate (HDR) Breast Brachytherapy
Baseline characteristics by cohort
| Measure |
Breast Brachytherapy to 34 Gy
n=127 Participants
breast brachytherapy to a dose of 34 Gy
brachytherapy: breast brachytherapy to 34 Gy
|
|---|---|
|
Age, Customized
Age 30-39
|
2 years
n=5 Participants
|
|
Age, Customized
Age 40-49
|
29 years
n=5 Participants
|
|
Age, Customized
Age 50-59
|
35 years
n=5 Participants
|
|
Age, Customized
Age 60-69
|
45 years
n=5 Participants
|
|
Age, Customized
Age 70-79
|
14 years
n=5 Participants
|
|
Age, Customized
Age 80-89
|
2 years
n=5 Participants
|
|
Sex: Female, Male
Female
|
127 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
1 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
123 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
3 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
2 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
124 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
1 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
127 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 5 yearsPopulation: No data are available as the study was terminated and PI has left the institution. Multiple efforts to contact the PI for the relevant data have failed. Sincere efforts were made to obtain the data for reporting, however, no data are available.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 3 yearsPopulation: No data are available as the study was terminated and PI has left the institution. Multiple efforts to contact the PI for the relevant data have failed. Sincere efforts were made to obtain the data for reporting, however, no data are available.
Outcome measures
Outcome data not reported
Adverse Events
Breast Brachytherapy to 34 Gy
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Diana Trask, research coordinator for study
UW Hospital and Clinics
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place